The Cancer Care 2024 CNE Nursing Conference, hosted by Mayo Clinic, offers an enriching educational experience for nurses in cancer care. This conference provides insights into the latest advancements, evidence-based practices, and patient care strategies in oncology nursing. Attendees will benefit from expert presentations, case studies, and interactive discussions to enhance their knowledge and skills in cancer care. Join fellow nurses and industry professionals in this dynamic event to stay updated on the evolving landscape of cancer care.

Read on go.evvnt.com

The 14th World Congress on Breast Cancer Research & Therapies, set for February 15-17, 2024, in Rome, Italy, unites global experts, oncologists, researchers, and healthcare professionals to advance breast cancer research and care. The mission is to foster collaboration, innovation, and knowledge exchange to combat breast cancer's multifaceted challenges. Key objectives include knowledge exchange, collaboration, patient-centric focus, education, and advocacy. The congress features plenary and scientific sessions, interactive workshops, poster presentations, and networking opportunities. It targets medical professionals, researchers, patients, and industry representatives, aiming to improve breast cancer prevention, diagnosis, and treatment worldwide. Market analysis indicates significant growth in the breast cancer therapeutics market.
Read on breastcancer.cancersummit.org

FRPT (Flash Radiotherapy and Particle Therapy) will take place on 5-7 December 2023 in Toronto and online.

FRPT looks to build a worldwide organisation of scientists and professionals interested in FLASH Radiotherapy using protons, electrons, heavier charged ions, and photons.

The Conference will bring together researchers and students with professionals working in clinical oncology (clinicians, medical physicists, dosimetrists, radiotherapy technologists, and nurses) and industry, and provide a multidisciplinary forum to discuss the latest developments in FLASH Radiotherapy.

FRPT goes from basic science, through preclinical research and combines these with translational applications and clinical trials and treatment.

Throughout the Conference, we will discuss all modalities related to FLASH-RT with the best international experts in the field: clinical trials, protocols, mechanism, new horizons and more. Participants will get access to the very latest progress on FLASH clinical devices, Metrology and dose monitoring, treatment planning systems, modeling, physio-chemistry, biological mechanisms, preclinical studies and clinical trials.

Read on frpt-conference.org

Attend the Great Debates & Updates in Women's Oncology, a complimentary virtual conference on November 1-3, providing insights into the latest advances and treatment decisions in breast and gynecological cancers. This unique event offers didactic presentations, interactive debates, and valuable take-home information on controversial topics in the field. Register for free or purchase on-demand access for up to 90 days to review treatment options and gain diverse perspectives. Don't miss this opportunity to stay updated and enhance patient care.

Read on go.evvnt.com

With 2023 witnessing critical partnerships and breakthrough data from the likes of Merck and Moderna, the mRNA Cancer Vaccine Summit 2023 comes to Boston as the community is on the cusp of something truly exciting. This unique event will unite the leading minds from the mRNA cancer vaccine community to provide a comprehensive and detailed roadmap towards accelerated discovery, translation and clinical development of an innovative next generation cancer treatment for patients in need.

Unite with mRNA cancer vaccine, oncology and immune-oncology leaders and stay up to date about these innovative cancer therapies, as our world class
speakers navigate through:

- Next generation techniques in personalized mRNA cancer vaccines to develop a more effective vaccine
- Optimizing the antigen selection process to ensure high clinical activity and high-quality immune responses
- Understanding the standards and regulatory requirements for mRNA cancer vaccines for rapid approvals and commercial readiness

With 23+ world class speakers, 3 days of unrivalled content, and over 10 hours of networking opportunities, this event is not to be missed.

Read on go.evvnt.com

Be at the forefront of the Bispecific space as it goes head to head with cell therapy to transform oncology. Among numerous innovations in cancer immunotherapy, Bispecific antibody treatments have never been more promising with continuous clinical updates and approvals over the last year, including the huge waves seen in multiple myeloma and lymphoma treatment.

The World Bispecific Summit returns for its 14th year with an enriched program boasting comprehensive coverage of all the key discovery, pre-clinical and clinical challenges including design, clinical, regulatory and combination strategies. Led by the industry's brightest minds from the likes of Sanofi, Regeneron, the FDA, Alligator Biosciences and Amgen, it's the perfect platform to celebrate wins, work through challenges and establish connections with the leading pharma, biotech and academic KOLs.  Deep dive into novel target selection, immune cell modulators, target selection and pre-clinical/clinical readouts and gain holistic insight on the current state-of-play in the bispecific landscape to supercharge your own pipeline from discovery through to IND approval.

Read on go.evvnt.com

The Multidisciplinary Neuro-Oncology Symposium is a two-day symposium designed to update participants on the diagnosis and management of primary and metastatic CNS tumors relevant to current medical practice. Through a combination of lectures, literature reviews, and case-based presentations, this symposium will deliver up-to-date and cutting-edge information that can be directly integrated into clinical practice.

Read on go.evvnt.com

Scripps MD Anderson Cancer Center's Annual Cancer Care Symposium is designed for nurses, nurse practitioners, physician assistants, clinical nurse specialists, and other health care professionals who treat cancer patients. During this two-day conference, participants will hear from expert faculty representing practice settings across the continuum of care as they discuss clinical developments and treatment advances in hematology and oncology. The 2023 symposium will provide important updates in onco-fertility, palliative care, advances in surgical oncology, pharmacology, cancer in transgender and gender-diverse populations and post-covid implications for cancer patients, as well as new treatments for various malignancies.

Read on go.evvnt.com

Join the premier meeting in Orlando, where you'll gain valuable insights into efficient and innovative approaches to enhance the lives of cancer patients. This weekend event brings together top experts in the field, providing you with powerful ideas and techniques that can be readily integrated into your clinical practice. Don't miss this opportunity to enhance your knowledge and make a meaningful impact on patient care.

Read on go.evvnt.com

Hematology / Oncology Patient Cancer Education Series - Prostate Cancer 2023

Mayo Clinic invites you to join us on Saturday, September 16, 2023 for an educational patient and caregiver symposium covering Prostate Cancer. This in-person and online event is free to join. It will take place at the Mayo Clinic Jacksonville Kinne Auditorium - 4500 San Pablo Rd S, Jacksonville, FL 32224

Attendees will be able to ask the expert speakers questions related to care, treatment options, finance and more.

Event Highlights

-Empowers patients with educational tools to understand and live with a diagnosis of prostate cancer.

-Provides new and innovative information on the current and future treatment options for prostate cancer.

-Educates attendees on comprehensive health needs for cancer patients.

-Provides an opportunity for patients and caregivers to interact with world renowned physicians and healthcare management teams in a safe and socially distant manner.

Read on go.evvnt.com

The 4th International Conference on Lymphocyte Engineering (ICLE 2023) will take place on 12-14 September 2023 in Munich, Germany.

ICLE is a cornerstone conference for the latest advances in immune-gene therapy, where ground-breaking research in the field is presented along with innovative clinical practices and treatment. Join the 2023 edition as it brings together immunotherapy with cell and gene therapy to foster interdisciplinary collaborations, deepening the connection between basic and clinical research across related disease specialties.

ICLE 2023 will once again take place in Munich - home to the biggest European research hub in the field, the perfect location for the only international conference focusing specifically on research and clinical translation of gene therapy, cell therapy, genome engineering, and immunotherapy.

Great strides have been made in recent years in the engineering of lymphocytes for the treatment of cancer, autoimmune diseases, pathogenic diseases, and primary immune deficiencies. Combining gene therapy, cell therapy and immune therapy, the emerging field of lymphocyte engineering employs cutting-edge technologies of viral and non-viral vectorology, genome editing, and protein design as well as advanced clinical protocols for cell harvest, expansion, and re-infusion and for the exciting alternative of in vivo engineering. With groundbreaking clinical success leading to FDA-approved products and with vibrant, exponentially growing research, lymphocyte engineering is the wave of the future.

Still, the challenges are formidable, and the stakes are high. Realizing the full promise of lymphocyte engineering will require the combined efforts of a dedicated community. ICLE 2023 will facilitate the sharing of data and ideas, promote collaborations, and address common challenges to advance clinical translation. It will provide an effective environment for active learning, discussions of real-world case studies, and networking between like-minded peers. Learn what is done to translate the lymphocyte engineering research to clinical practice and how your colleagues overcome their challenges. Hear from renown leaders, sharing invaluable insights on lymphocyte engineering therapies and discuss the latest findings and trends.

Whether you are a scientist, clinical researcher, part of a start-up, or an established industry company, ICLE 2023 is your opportunity to network and discuss immuno-gene therapy with those as excited and passionate about this innovative treatment modality.

Read on kenes.com

Following the success of previous physical and virtual editions of ICC Conference series, we are pleased to announce that its “6th Edition of International Cancer Conference” (ICC 2023) will be a Hybrid meeting, taking place onsite in London, UK and online via a virtual platform on August 17-19, 2023.

The Cancer Conferences 2023 strives to provide a meaningful theme of  “Stretching Wings to Fight Cancer through Unified Research Approaches.”

Patients with cancer and their needs are at the center of all we do, and we're dedicated to improving research and integrating it into the clinic to provide better treatment for them. We aim to provide a full summary of all practice-changing new data, as well as a clear path to the clinic.

Patients with cancer and their needs are at the center of all we do, and we're dedicated to improving research and integrating it into the clinic to provide better treatment for them. Oncology Conference strives to provide a global podium which will include a broad range of topics in fundamental, preclinical, and translational cancer research. Cancer Events will feature the most recent trends and innovations and bring together the cancer research community in order to stimulate innovation and foster knowledge, connections, and collaborations.
Read on magnusconferences.com

Scripps MD Anderson Cancer Center's 2023 Oncology Update is a one-day conference designed to offer clinicians and advanced practice providers a comprehensive overview of the most recent advances in the treatment of various oncologic malignancies. During this comprehensive educational course, clinical experts in the fields of hematology and oncology will provide an overview of key findings from practice changing studies and the latest clinical data. Esteemed faculty will review exciting and important abstracts and discuss their relevance to the clinical oncology practice.

Read on go.evvnt.com

This one-day CME course provides hematology and oncology clinicians, nurse practitioners, and physician assistants with an overview of the most recent advances in the treatment of various oncologic malignancies, based on abstracts presented at the June 2023 annual meeting of the American Society of Clinical Oncology (ASCO). Invited speakers choose exciting and relevant abstracts presented at the ASCO meeting and discuss their clinical relevance to daily practice.

Read on go.evvnt.com

Scripps MD Anderson Cancer Center's 2023 Oncology Update is a one-day conference designed to offer clinicians and advanced practice providers a comprehensive overview of the most recent advances in the treatment of various oncologic malignancies. During this comprehensive educational course, clinical experts in the fields of hematology and oncology will provide an overview of key findings from practice changing studies and the latest clinical data. Esteemed faculty will review exciting and important abstracts and discuss their relevance to the clinical oncology practice.

Read on go.evvnt.com

Scripps MD Anderson Cancer Center's 2023 Oncology Update is a one-day conference designed to offer clinicians and advanced practice providers a comprehensive overview of the most recent advances in the treatment of various oncologic malignancies. During this comprehensive educational course, clinical experts in the fields of hematology and oncology will provide an overview of key findings from practice changing studies and the latest clinical data. Esteemed faculty will review exciting and important abstracts and discuss their relevance to the clinical oncology practice.

Read on go.evvnt.com

With 9 preclinical candidates actively being studied and 21 clinical trials taking place, the Adenosine landscape is bubbling with activity! No stone is left unturned as CD73, CD39, A1AR, A2AR, and Interior adenosine pathways are exploited. The field is poised to leap on the momentum from clinical success at the 2nd Annual Adenosine-Pathway Targeted Cancer Immunotherapy Summit.

Returning as the premier event devoted to improving the efficacy of drugs that target the adenosine pathway, overcoming obstacles related to resistance and immunosuppression, and accelerating the translation of therapeutics into the clinic.

Join experts in adenosine, immune checkpoint, tumor microenvironment, immune-oncology, and second-generation IO as they learn how combination medicines might improve the effectiveness and potency of treatment.

With more speakers, content, and networking opportunities than ever before, don't miss this opportunity to overcome these obstacles and exploit the adenosine pathway's therapeutic and commercial potential.

Read on adenosine-pathway-immunotherapy.com

DEAR COLLEAGUES,

on behalf of the scientific management, I would like to invite you to an intensive interdisciplinary and scientific exchange at the GI-Oncology 2023, which will now take place for the second time in the RheinMain CongressCenter. As before, the focus of the event is the evaluation of new therapy concepts and procedures and the discussion of new perspectives for diagnostics and biomarkers in gastrointestinal tumors. As usual, the sessions are organ-related with a clear focus on interdisciplinary and multidisciplinary diagnostics and therapy. Of course, "tumor-agnostic" concepts will also play a role.

Of course, we would also like to present you with the latest study results from the entire spectrum of gastrointestinal oncology and place them in clinical practice. In the program you will therefore also find an oncology "hotspot" in which new information from current congresses is presented in a pointed manner.

Read on go.evvnt.com

The Targeted Protein Degradation Europe Summit returns to London for its 3rd year, providing a central touchpoint to obtain critical updates and learnings from key European biopharma leaders, and delve into vital early discovery and preclinical challenges on the road to robust clinical pipelines.

As the first ever fully in-person meeting, 160+ leading Medicinal Chemists, Biologists, Heads of Discovery and R&D and Pre-Clinical and Translational Development experts from Europe and across the globe will unite. Make sure you are a part of this community to strengthen your pipelines and stay ahead of the curve as the next generation of protein degraders are defined.

Read on tpd-europe.com

The 2023 Clinical Hematology and Oncology Conference, presented by Scripps MD Anderson Cancer Center, is designed for hematologists, oncologists, surgeons, radiation oncologists, internists, and others desiring an update in these specialty areas. The primary objective of this course is to bring together clinicians and leading experts in diverse areas of hematology and oncology, affording them an intimate environment in which to discuss new clinical developments and significant advances.

For 15 years now, the TZM Essentials have been an integral part of the calendar. We are very pleased to be able to offer you the TZM Essentials again in 2023 and are confident that we will be able to hold the event as usual as a one-day face-to-face event on February 11, 2023 in the Klinikum Rechts der Isar of the TU Munich.

Traditionally, the focus is on imparting current practice-relevant, oncological and haematological knowledge. As always, we attach great importance to the fact that the knowledge of the last 12 months is selected and evaluated and classified by experts. In 2023 we will again offer a cross-section of clinically relevant topics across the various oncological disciplines. The speakers perfectly represent the interface between science and clinical practice.

Read on go.evvnt.com

With 2023 on track to see further growth in the immuno-oncology field, the availability of tools that offers drug developers & researchers advantages that weren’t available to them even a few years ago is increasing rapidly. Despite this growth over the last 12 months, the IO community still faces critical challenges in translating drugs to the clinic. The IO community must continue to work together to overcome critical bottlenecks around immunomodulating agent utilization, dosing and efficacy as well as looking for predictive biomarkers to boost our clinical and therapeutic index confidence. 

Read on tumor-models-sf.com

With next generation of complex immuno-oncology candidates, preclinical and translational scientists in the IO space are in need for more predictive tumour models to improve clinical translatability, accelerating speed-to-clinic with confidence.

We are excited to finally reunite this community in December at 11th PREDiCT: Tumour Models London Summit to address the critical next step of narrowing the preclinical gap and progressing efficacious candidates to the clinic.

This much-anticipated in-person meeting will unite 120+ pioneers to help you:

Benchmark against peers' in vivo and in vitro model selection strategy for novel IO, in conjunction with NK and macrophages interaction with TME, to maximise translatability

Evaluate and compare next generation tumour models for TME, cell-cell interaction, immune response and drug response to guide clinical design and patient selection

Accelerate off-the-shelf humanised and PDX model development for NK, allogenic cell therapies

Rigorously test, characterise, validate novel cancer models to support adoption and ensure quality control in preclinical studies

Engage with leading academics and CROs to drive long-term partnerships and fuel model innovations

This is your must-attend tumour model summit to reconnect with fellows from Pfizer, Sanofi, GSK, and propel your clinical progression with confidence in 2023!

This important educational activity will provide guidance to front-line and oncology clinicians, nurses, physicians, pharmacists, nurse practitioners, physician assistants and pharmacists, with the most current information available about new agents in oncology and translating of the latest research to their patients. The conference will cover drug and treatment updates with a focus on myeloma, gynecological malignancies, hematologic malignancies, sarcoma, bladder cancer and GI malignancies. The conference features a comprehensive review of new drugs approved along with their mechanism of action, next generation CAR-T cell therapies and a keynote lecture, Stand Up to Cancer focusing on developmental therapeutics. Next generation studies will also be addressed, and the conference will offer participants a session designed to provide insight into the latest advances in lung cancer treatment, including integration of new molecularly-targeted therapies and immunotherapy.

This two-and-a-half-day continuing medical education course provides a multidisciplinary update in prevention, evaluation, diagnosis, management, and treatment of benign and malignant breast diseases, and high risk and survivorship issues. The course has multidisciplinary experts in their field presenting the latest, diagnostic, treatment and management options. Highlights include, genetics and high-risk management, breast imaging modalities, supplemental screening options for dense breasts, and more.

Venue details: DoubleTree Resort by Hilton Hotel Paradise Valley - Scottsdale, 5401 North Scottsdale Road, Scottsdale, Arizona, 85250, United States